Retraction: Effect of Fasudil on remyelination following cuprizone-induced demyelination

Jing Wang; Ruo-Xuan Sui; Qiang Miao; Qing Wang; Li-Juan Song; Jie-Zhong Yu; Yan-Hua Li; Bao-Guo Xiao; Cun-Gen Ma

doi:10.1111/cns.13393

Retraction: Effect of Fasudil on remyelination following cuprizone-induced demyelination

CNS Neurosci Ther. 2020 Jul;26(7):778. doi: 10.1111/cns.13393. Epub 2020 May 27.

Authors

Jing Wang¹, Ruo-Xuan Sui², Qiang Miao², Qing Wang², Li-Juan Song², Jie-Zhong Yu³, Yan-Hua Li³, Bao-Guo Xiao⁴, Cun-Gen Ma^{1

2

3}

Affiliations

¹ Department of Neurology, First Affiliated Hospital, Shanxi Medical University, Taiyuan, China.
² The Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple Sclerosis of State Administration of Traditional Chinese Medicine, Shanxi University of Traditional Chinese Medicine, Taiyuan, China.
³ Institute of Brain Science, Shanxi Datong University, Datong, China.
⁴ Institute of Neurology, Huashan Hospital, Institutes of Brain Science and State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China.

Abstract

Retraction: Wang J, Sui R-X, Miao Q, et al. Effect of Fasudil on remyelination following cuprizone-induced demyelination. CNS Neuroscience & Therapeutics, 2020;26:76-89. https://doi.org/10.1111/cns.13154. The above article published online on May 23, 2019, in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief, Professor Jun Chen, and John Wiley & Sons Ltd. The retraction has been agreed due to major overlap with a previously published article from the same group of authors.

Publication types

Retraction of Publication